Back to Search
Start Over
RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1[alpha] and inhibition phosphorylation of AKT and mTOR.
- Source :
-
Cancer Chemotherapy & Pharmacology . Jun2012, Vol. 69 Issue 6, p1633-1640. 8p. - Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 03445704
- Volume :
- 69
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Cancer Chemotherapy & Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 104454300
- Full Text :
- https://doi.org/10.1007/s00280-012-1873-3